A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a single arm, multi-center, phase II trial to evaluate the efficacy, and safety of adebrelimab combined with famitinib and chemotherapy for the treatment of first-line extensive stage small cell lung cancer.
Epistemonikos ID: 422fdf78b26333ef2d32d07ef388932116529c31
First added on: May 15, 2024